The Research Scholars Program supports innovative research from emerging investigators around the world to incorporate new perspectives in our pursuit of scientific understanding and progress. We believe that new voices and research topics are needed to advance scientific knowledge in areas of unmet medical need and create a healthier world.

The program is designed to support any pre-clinical or clinical research limited to breast, bladder, or lung cancer that addresses an unmet medical need in the field of Oncology Solid Tumors in Europe, Australia, and Canada.

The Solid Tumors program provides a minimum of 3 awards.

Each award is funded up to $180,000 USD for two years, to be paid in annual instalments of up to $90,000 USD per year (Aaward value is subject to country regulations)

Applications will be reviewed and selected by an independent Scientific Review Committee comprised of internationally recognised experts in basic, translational, and clinical research in the field of Oncology Solid Tumors. Not all applications will be selected.

Gilead’s Research Scholars Program is committed to building a more diverse and inclusive scientific community.

Eligibility Criteria

Applicant must have:

  • Hold an MD, or PhD, (or equivalent degree) at time of award. MD qualifications would have to have been obtained within the last 10 years and PhD qualifications would have to have been obtained within the last 5 years ;

  • Early to Mid-career scientists with a strong research track record who hold a position as a recognised research institution in one of the eligible countries at the time of application and whose tenure of that position encompasses the projected period of the award from the Gilead scholarship program ;

  • Have a strong career interest in Oncology Solid Tumors ;

  • Have a research mentor with extensive experience in the field of Oncology Solid Tumors ;

  • Be able to devote at least 30% of their professional time to research for the next two years ;

  • Be able to complete the proposed research within the 2-year award period.


Download the brochure

Application Deadline: 15 March 2024, 11:59 PM, Central European Time